33 related articles for article (PubMed ID: 10092985)
21. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
Ranganath LR; Beety JM; Morgan LM
Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
[TBL] [Abstract][Full Text] [Related]
22. Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1).
Ranganath L; Schaper F; Gama R; Morgan L; Wright J; Teale D; Marks V
Diabetes Metab Res Rev; 1999; 15(6):390-4. PubMed ID: 10634963
[TBL] [Abstract][Full Text] [Related]
23. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
24. Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects.
Ranganath LR; Beety JM; Wright J; Morgan LM
Horm Metab Res; 2001 Jan; 33(1):57-61. PubMed ID: 11280717
[TBL] [Abstract][Full Text] [Related]
25. The effect of circulating non-esterified fatty acids on the entero-insular axis.
Ranganath L; Norris F; Morgan L; Wright J; Marks V
Eur J Clin Invest; 1999 Jan; 29(1):27-32. PubMed ID: 10092985
[TBL] [Abstract][Full Text] [Related]
26. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
Creutzfeldt W
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
[TBL] [Abstract][Full Text] [Related]
27. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster.
Egan BM; Lu G; Greene EL
Prostaglandins Leukot Essent Fatty Acids; 1999; 60(5-6):411-20. PubMed ID: 10471131
[TBL] [Abstract][Full Text] [Related]
28. The Interplay between Non-Esterified Fatty Acids and Plasma Zinc and Its Influence on Thrombotic Risk in Obesity and Type 2 Diabetes.
Hierons SJ; Marsh JS; Wu D; Blindauer CA; Stewart AJ
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576303
[TBL] [Abstract][Full Text] [Related]
29. Biological complexity is under the 'strange attraction' of non-esterified fatty acids.
Nunez EA
Prostaglandins Leukot Essent Fatty Acids; 1997 Jul; 57(1):107-10. PubMed ID: 9250616
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
